# Systemic antihyperalgesic effect of a novel conotoxin from Californiconus californicus in an inflammatory pain model

**Authors:** Joaquín López-Carrillo, Johanna Bernáldez-Sarabia, Tushar J. Pawar, Samanta Jiménez, Salvador Dueñas, Andrea Figueroa-Montiel, José L. Olivares-Romero, Vinicio Granados-Soto, Alexei F. Licea-Navarro, Nadia L. Caram-Salas

PMC · DOI: 10.3389/fpain.2024.1500789 · Frontiers in Pain Research · 2025-01-24

## TL;DR

A new conotoxin from a California cone snail shows strong pain-relieving effects in a rat model of inflammation without affecting movement.

## Contribution

O1_cal6.4b, a novel conotoxin, demonstrates superior analgesic effects compared to existing conotoxins and standard pain medications.

## Key findings

- Systemic administration of O1_cal6.4b reduced thermal hyperalgesia without impairing motor coordination.
- O1_cal6.4b showed better analgesic effects than O1_cal6.4d, ω-MVIIA, and standard analgesics.
- Structural differences between O1_cal6.4b and O1_cal6.4d suggest unique functional properties.

## Abstract

This study explores the analgesic potential of the novel conotoxin O1_cal6.4b, derived from Californiconus californicus, as a candidate for pain management in a model of inflammatory pain.

O1_cal6.4b was systemically administered to Wistar rats, and its effects on thermal hyperalgesia and motor coordination were evaluated. Comparative analyses were conducted against O1_cal6.4d, ω-MVIIA, and standard analgesics (morphine, dexamethasone, and diclofenac). Structural differences between O1_cal6.4b and O1_cal6.4d were examined using in silico modeling and molecular dynamics simulations.

Systemic administration of O1_cal6.4b significantly reduced thermal hyperalgesia in a dose-dependent manner without impairing motor coordination. The analgesic effect of O1_cal6.4b was superior to that of O1_cal6.4d, ω-MVIIA, and standard analgesics. Structural analyses revealed notable differences between O1_cal6.4b and O1_cal6.4d, suggesting unique functional properties.

The findings indicate that O1_cal6.4b exhibits a promising analgesic profile with advantages over traditional opioid-based therapies. These results underscore the molecular diversity of conotoxins and highlight their potential as innovative analgesic treatments. Further research is needed to elucidate the mechanism of action of this novel conotoxin.

## Linked entities

- **Chemicals:** morphine (PubChem CID 5288826), dexamethasone (PubChem CID 5743), diclofenac (PubChem CID 3033)
- **Species:** Californiconus californicus (taxon 1736779)

## Full-text entities

- **Diseases:** thermal hyperalgesia (MESH:D006930), inflammatory pain (MESH:D010146)
- **Chemicals:** diclofenac (MESH:D004008), O1_cal6.4b (-), dexamethasone (MESH:D003907), morphine (MESH:D009020)
- **Species:** Californiconus californicus (species) [taxon 1736779], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11802583/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11802583/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC11802583/full.md

---
Source: https://tomesphere.com/paper/PMC11802583